No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1197 |
4. Check minimum number of eventsNone |
1197 |
5. Include endpointsNone |
1197 |
6. Filter based on genotype QC (FinnGen only) |
1039 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified epidermal thickening
based on the number of shared cases.
Similar with more cases:
- Other epidermal thickening
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7347 | 3872 | 3440 |
| Only index persons | 6683 | 3612 | 3071 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.10 | 0.11 | 0.10 |
| Only index persons | 0.13 | 0.13 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 51.27 | 51.51 | 50.95 |
| Only index persons | 51.20 | 51.44 | 50.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1039 | 574 | 465 |
| Unadjusted period prevalence (%) | 0.21 | 0.20 | 0.21 |
| Median age at first event (years) | 55.39 | 52.12 | 59.43 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1086
- Matched controls
- 10860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L85.89
ICD-10 Finland
Other specified epidermal thickening
+∞
322.5
293
*
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
+∞
307.7
374
*
L85.81
ICD-10 Finland
Keratosis pilaris
1619.3
268.3
250
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
10.8
239.4
304
379
L85.80
ICD-10 Finland
Hudhorn
245.7
183.5
184
9
D05BB02
ATC
acitretin; oral
18.2
154.1
128
79
D02AE01
ATC
carbamide; topical
8.3
147.8
219
321
D07XC01
ATC
betamethasone; topical
6.1
147.2
317
684
E0000UV, ,
ATC
4.8
135.9
724
3197
L84
ICD-10 Finland
Corns and callosities
13.9
127.7
123
99
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.4
119.5
434
1418
TQW80
NOMESCO Finland
Local dermatologic skincare
14.5
116.8
109
83
L85.3
ICD-10 Finland
Xerosis cutis
27.9
106.6
73
28
R4180
NOMESCO Finland
Podiatric therapy
24.3
104.1
75
33
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
11.5
96.7
104
99
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
20.4
89.1
69
36
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
22.7
75.8
56
26
D07AD01
ATC
clobetasol; topical
3.8
74.3
288
946
E000003, ,
ATC
6.3
67.6
122
215
D07AC01
ATC
betamethasone; topical
3.0
67.4
529
2626
L57.0
ICD-10 Finland
Actinic keratosis
4.2
65.0
200
555
L30.4
ICD-10 Finland
Erythema intertrigo
12.6
54.3
54
45
B07.9
ICD-10 Finland
Verruca simplex
6.1
53.2
97
172
E000001, ,
ATC
2.9
52.1
320
1357
E000006, ,
ATC
4.6
51.7
135
328
L40.0
ICD-10 Finland
Psoriasis vulgaris
5.6
49.4
98
188
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
8.1
48.9
67
87
D07AC13
ATC
mometasone; topical
2.6
45.0
398
2007
B35.3
ICD-10 Finland
Tinea pedis
5.1
44.3
98
207
L04AA06
ATC
mycophenolic acid; systemic
9.4
43.7
53
59
A12AA04
ATC
calcium carbonate; oral
11.7
43.3
45
40
D05AX52
ATC
calcipotriol, combinations; topical
4.7
42.4
103
235
127
Kela drug reimbursment
Transplant complication
10.0
41.5
48
50
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.5
41.3
158
502
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.2
41.0
193
697
L04AA01
ATC
[U] ciclosporin
10.9
39.5
43
41
A46
ICD-10 Finland
Erysipelas
2.9
39.4
214
837
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.3
39.4
82
164
D05AX02
ATC
calcipotriol; topical
5.5
39.0
79
154
D07BC01
ATC
betamethasone and antiseptics; topical
3.1
37.5
181
661
XQ848
NOMESCO Finland
Dermatological photography
6.1
36.5
65
112
D07AB08
ATC
desonide; topical
3.1
36.5
173
625
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
7.6
36.3
52
71
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.9
36.0
204
813
D09AB01
ATC
zinc bandage without supplements; topical
9.0
36.0
45
52
L04AD01
ATC
ciclosporin; systemic
7.8
35.5
50
67
L04AX01
ATC
azathioprine; systemic
4.9
35.1
80
173
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
7.1
34.6
53
78
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.4
34.1
138
452
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.8
33.1
108
307
TK800
NOMESCO Finland
Hemodialysis
8.1
33.0
45
58
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.1
32.9
50
73
Z94.0
ICD-10 Finland
Kidney transplant status
11.7
32.8
34
30
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.4
32.0
298
1502
S97
ICPC
Chronic ulcer skin
4.0
31.8
96
258
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.3
31.6
47
67
70119
ICD-8 Finland
Other hypertrophic and atrophic conditions of the skin, Keratosis, hyperkeratosis alia sive NUD
+∞
31.4
30
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
28.0
565
3794
J01FF01
ATC
clindamycin; systemic
2.2
27.9
327
1797
ZXC50
NOMESCO Finland
Cryotherapy
5.6
27.8
54
101
S18
ICPC
Laceration/cut
2.0
27.6
558
3744
E000002, ,
ATC
2.7
26.6
160
652
SPAT1153
SPAT
Removal of sutures
2.1
26.6
369
2157
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
26.5
353
2032
C03CA01
ATC
furosemide; systemic
2.1
26.5
349
2001
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.6
26.3
180
782
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.7
26.0
153
616
E000004, ,
ATC
6.0
25.9
46
79
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
7.5
25.6
37
51
A11CC03
ATC
alfacalcidol; systemic
5.5
25.3
50
95
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
6.3
25.2
43
71
J01DB01
ATC
cefalexin; oral
2.5
24.8
927
7639
D01AE15
ATC
terbinafine; topical
3.1
23.2
103
355
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
23.2
280
1542
H02AB06
ATC
prednisolone; systemic
1.9
23.2
531
3644
-, ,
ICD-10 Finland
5.3
23.0
47
92
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
22.2
158
697
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
21.9
354
2155
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
21.8
97
335
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.3
21.7
181
857
D02AX
ATC
Other emollients and protectives
4.4
21.6
56
134
E000007, ,
ATC
3.2
21.3
87
285
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
5.1
21.3
45
91
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.2
21.3
26
29
UJF32
NOMESCO Finland
Coloscopy
2.0
20.5
299
1751
D05AX03
ATC
calcitriol; topical
8.0
20.5
28
36
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
5.2
20.4
42
83
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.6
20.3
49
111
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
6.9
20.0
31
46
L04AD02
ATC
tacrolimus; systemic
7.9
19.6
27
35
L89
ICD-10 Finland
Decubitus ulcer and pressure area
19.8
19.6
29
15
D07AA02
ATC
hydrocortisone; topical
2.2
19.4
186
931
L30.8
ICD-10 Finland
Other specified dermatitis
4.3
19.2
50
120
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
5.7
19.2
36
65
J01CE08
ATC
benzathine benzylpenicillin; parenteral
8.0
19.2
26
33
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
6.7
18.8
30
46
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.4
18.8
142
641
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
18.5
123
523
TQW99
NOMESCO Finland
Other minor procedure on skin
3.2
17.8
71
229
B35.1
ICD-10 Finland
Tinea unguium
2.7
17.7
99
387
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.4
17.6
135
613
XQ802
NOMESCO Finland
Epicutan test
3.4
17.5
64
196
SPAT1312
SPAT
General health counselling
1.8
17.3
365
2385
A10AE04
ATC
insulin glargine; parenteral
2.4
17.3
123
540
S20
ICPC
Corn/callosity
5.0
17.2
37
76
L82
ICD-10 Finland
Seborrhoeic keratosis
2.1
17.2
194
1031
D01BA02
ATC
terbinafine; oral
1.9
17.1
287
1747
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.7
17.1
27
41
L30.3
ICD-10 Finland
Infective dermatitis
3.6
16.9
57
165
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
16.8
216
1202
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
15.3
16.7
27
18
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
15.3
16.7
27
18
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.8
16.7
38
82
ZXC15
NOMESCO Finland
Use of photodynamic technique
6.8
16.6
26
39
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.1
16.6
46
116
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
16.6
357
2342
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.9
16.5
80
289
A10AB05
ATC
insulin aspart; parenteral
2.7
16.5
96
383
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.9
16.4
250
1473
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.3
16.4
130
599
RJ411, ,
NOMESCO Finland
17.0
16.1
25
15
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
18.8
16.0
24
13
J02AC01
ATC
fluconazole; systemic
1.7
15.9
404
2771
ZZA00
NOMESCO Finland
Split skin graft
4.3
15.7
41
99
R50.9
ICD-10 Finland
Fever, unspecified
2.0
15.6
187
1013
L85.1
ICD-10 Finland
Acquired keratosis [keratoderma] palmaris et plantaris
86.4
15.6
17
*
SPAT1249
SPAT
Treatment-related counselling outside office
1.7
15.6
427
2986
A10AB04
ATC
insulin lispro; parenteral
3.7
15.5
50
141
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.7
15.4
447
3171
XCD10
NOMESCO Finland
Electrophysiological examination of eye
4.4
15.4
39
92
A07AA09
ATC
vancomycin; oral
6.2
15.2
26
43
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
23.8
15.1
21
9
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.1
15.1
63
209
SPAT1263
SPAT
Sampling
1.7
15.0
455
3259
A10AC01
ATC
insulin (human); parenteral
2.5
15.0
95
395
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.1
14.9
64
216
S29
ICPC
Skin symptom/complaint other
1.9
14.9
235
1395
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.8
14.8
307
1979
SPAT1301
SPAT
No procedures
1.7
14.8
345
2301
L04AX03
ATC
methotrexate; systemic
2.3
14.7
115
526
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.0
14.7
66
229
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
14.6
442
3160
L20.0
ICD-10 Finland
Besnier prurigo
2.4
14.6
107
476
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.4
14.5
54
167
137
Kela drug reimbursment
Uraemia requiring dialysis
12.8
14.4
25
20
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
6.5
14.1
23
36
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
14.1
401
2813
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.0
14.1
30
61
ZX120
NOMESCO Finland
Intravenous
2.3
14.1
115
536
H02AB04
ATC
methylprednisolone; systemic
2.1
14.0
155
814
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
14.0
77
298
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.1
14.0
152
793
J01DA01
ATC
[U] cefalexin
1.6
13.9
643
5091
S76
ICPC
Skin infection other
2.8
13.9
73
276
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
17.8
13.9
21
12
R06AE07
ATC
cetirizine; oral
1.6
13.8
472
3465
A10AA01, ,
ATC
3.9
13.8
41
109
D01AC02
ATC
miconazole; topical
2.4
13.7
95
411
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.9
13.6
65
233
D06BB10
ATC
imiquimod; topical
2.7
13.6
73
279
H02AB09
ATC
hydrocortisone; systemic
4.0
13.5
38
97
L91.0
ICD-10 Finland
Hypertrophic scar
16.5
13.5
21
13
L01BA01
ATC
methotrexate; systemic
3.6
13.5
44
125
XQ800
NOMESCO Finland
Prick test
2.4
13.4
93
403
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.4
13.4
33
76
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
12.3
13.1
23
19
A10AA02, ,
ATC
3.5
13.1
46
137
SPAT1262
SPAT
Handing over of treatment supplies
1.9
13.1
186
1064
SPAT1101
SPAT
Orthostatic test
3.2
13.1
53
173
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.7
13.0
329
2229
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
13.0
178
1006
L73.8
ICD-10 Finland
Other specified follicular disorders
6.2
13.0
22
36
XQ845
NOMESCO Finland
Dermatoscopy
4.5
12.9
31
70
L40.9
ICD-10 Finland
Psoriasis, unspecified
4.9
12.9
28
58
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
5.4
12.8
25
47
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
10.6
12.8
24
23
D07CC01
ATC
betamethasone and antibiotics; topical
2.0
12.8
146
775
N02AX02
ATC
tramadol; systemic, rectal
1.6
12.7
440
3225
SPAT1229
SPAT
Assessment of need for aid
2.4
12.6
87
376
N18.8
ICD-10 Finland
Other chronic renal failure
4.2
12.6
33
80
L20.8
ICD-10 Finland
Other atopic dermatitis
5.1
12.5
26
52
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
12.3
115
566
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
4.3
12.3
31
73
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
12.2
262
1695
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
16.1
12.2
19
12
A10AE05
ATC
insulin detemir; parenteral
2.6
12.1
70
278
G47.3
ICD-10 Finland
Sleep apnoea
1.7
12.1
246
1567
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
18.3
12.1
18
10
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
12.0
59
215
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.5
12.0
77
322
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
12.0
108
524
D01AE16
ATC
amorolfine; topical
2.1
11.8
123
631
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
3.4
11.7
43
132
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.9
11.7
55
196
RJ420, ,
NOMESCO Finland
16.6
11.7
18
11
L30.0
ICD-10 Finland
Nummular dermatitis
3.0
11.7
53
185
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.9
11.6
53
186
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.4
11.5
81
353
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
3.4
11.4
41
124
Q82.82
ICD-10 Finland
Inherited keratosis palmaris et plantaris
121.3
11.4
12
*
WW200
NOMESCO Finland
Immunization
3.7
11.4
36
100
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
11.4
212
1315
L50.3
ICD-10 Finland
Dermatographic urticaria
4.0
11.3
32
82
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
11.3
129
683
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
11.3
100
481
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.8
11.3
58
217
E66.01
ICD-10 Finland
Obesity due to excess calories
2.1
11.3
113
571
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
11.2
277
1854
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
11.2
254
1664
B03XA01
ATC
erythropoietin; parenteral
8.2
11.1
24
30
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
11.1
182
1086
J01CF05
ATC
flucloxacillin; systemic
2.3
11.0
87
399
H3600, E103,
ICD-10 Finland
5.8
11.0
20
35
L17
ICPC
Foot/toe symptom/complaint
1.6
10.9
331
2332
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
10.8
598
4814
R06.0
ICD-10 Finland
Dyspnoea
1.6
10.8
286
1946
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
3.5
10.8
37
109
SPAT1234
SPAT
Support of social functional capacity
2.6
10.8
63
252
A10AB01
ATC
insulin (human); parenteral
3.1
10.8
45
150
C02AC05
ATC
moxonidine; oral
2.7
10.6
57
218
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
10.6
114
591
SPAT1147
SPAT
Destruction of skin lesion with external methods
4.3
10.6
27
64
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
10.5
273
1848
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
10.5
247
1630
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.1
10.5
98
482
R03BA02
ATC
budesonide; inhalant
1.7
10.4
195
1208
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.2
10.3
88
417
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
10.7
10.3
19
18
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.1
10.3
108
555
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
3.6
10.3
33
93
C08CA02
ATC
felodipine; oral
2.1
10.2
99
493
C08CA05
ATC
nifedipine; systemic
2.5
10.2
65
271
C07AB02
ATC
metoprolol; systemic
1.7
10.1
200
1258
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.3
10.1
75
335
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
10.1
84
394
SPAT1325
SPAT
Vaccination
1.6
10.1
347
2507
H03AA01
ATC
levothyroxine sodium; systemic
1.7
10.1
237
1562
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
10.2
10.0
19
19
J02AC02
ATC
itraconazole; systemic
1.8
10.0
173
1047
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
10.0
221
1433
B03XA02
ATC
darbepoetin alfa; parenteral
3.9
10.0
29
76
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
3.9
10.0
29
76
N02BE01
ATC
paracetamol; systemic, rectal
1.8
10.0
944
8530
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
40.5
10.0
12
*
J01MA02
ATC
ciprofloxacin; systemic
1.5
10.0
379
2799
J45.8
ICD-10 Finland
Mixed asthma
3.2
10.0
39
125
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
9.9
34
100
V03AE02
ATC
sevelamer; oral
16.9
9.9
15
9
D06BX02
ATC
ingenol mebutate; topical
5.2
9.9
20
39
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
3.8
9.8
29
77
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
3.3
9.8
36
111
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
9.6
9.8
19
20
R60.0
ICD-10 Finland
Localized oedema
1.9
9.8
134
755
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
9.7
116
624
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
9.7
72
322
B01AC04
ATC
clopidogrel; oral
1.8
9.7
168
1018
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
9.6
85
409
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.7
9.6
182
1131
N03AX12
ATC
[U] gabapentin; oral
1.8
9.6
166
1005
NH3BG
NOMESCO Finland
MRI of foot
8.5
9.6
20
24
J01MA14
ATC
moxifloxacin; systemic
2.1
9.6
94
471
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
9.5
230
1525
K92.1
ICD-10 Finland
Melaena
2.4
9.4
67
294
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
12.5
9.4
16
13
205
Kela drug reimbursment
Chronic hypertension
1.6
9.3
249
1690
B05DA
ATC
Isotonic solutions
10.8
9.3
17
16
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.2
258
1770
QDB10, ,
SPAT
3.3
9.2
35
110
CKC12
NOMESCO Finland
Photocoagulation of retina
2.7
9.2
48
181
C03DA01
ATC
spironolactone; oral
1.9
9.2
129
732
A02BC02
ATC
pantoprazole; systemic
1.5
9.2
691
5842
C09AA02
ATC
enalapril; systemic
1.7
9.2
184
1161
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.9
9.1
42
148
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.9
9.1
42
148
J04AB02
ATC
rifampicin; systemic
5.1
9.1
19
38
M04AA01
ATC
allopurinol; systemic
1.9
9.1
128
727
R06AX22
ATC
ebastine; oral
1.7
9.1
175
1091
N91.1
ICD-10 Finland
Secondary amenorrhoea
4.0
9.1
25
63
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
9.1
266
1845
T82
ICPC
Obesity
2.6
9.1
52
206
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
11.6
9.1
16
14
NH3CG
NOMESCO Finland
Extensive MRI of foot
9.1
9.0
18
20
S21
ICPC
Skin texture symptom/complaint
1.8
9.0
161
982
N05AH04
ATC
quetiapine; oral
1.7
9.0
192
1230
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
9.0
138
805
J01FA06
ATC
roxithromycin; oral
1.5
9.0
385
2903
NHQ40
NOMESCO Finland
Amputation of toe
7.5
8.9
20
27
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
8.9
45
167
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
8.9
151
908
SPAT1310
SPAT
Counselling related to known health issue
1.5
8.9
321
2333
S06
ICPC
Rash localized
2.3
8.9
65
289
N05BA04
ATC
oxazepam; oral
1.6
8.9
269
1880
H04AA01
ATC
glucagon; nasal, parenteral
3.3
8.8
32
98
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
8.8
144
857
L60.0
ICD-10 Finland
Ingrowing nail
2.4
8.8
60
259
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
8.8
198
1288
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
8.8
92
473
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.0
8.7
97
509
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
8.7
196
1273
SPAT1260
SPAT
Consultation of another employee
1.7
8.7
174
1096
E66.8
ICD-10 Finland
Other obesity
2.3
8.6
64
286
R42
ICD-10 Finland
Dizziness and giddiness
1.6
8.6
231
1568
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
11.7
8.6
15
13
A07AA02
ATC
nystatin; oral
2.3
8.6
64
287
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
8.6
85
428
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
20.2
8.5
12
6
N03AX16
ATC
[U] pregabalin
1.6
8.5
221
1489
C07AB07
ATC
bisoprolol; oral
1.5
8.4
470
3721
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
8.4
136
806
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.2
8.4
70
329
S03
ICPC
Warts
3.4
8.4
29
86
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
8.4
225
1526
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.4
8.4
58
252
R03AC02
ATC
salbutamol; inhalant
1.5
8.4
564
4629
L85.8
ICD-10 Finland
Other specified epidermal thickening
+∞
8.3
8
*
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
8.3
8
*
M79.6
ICD-10 Finland
Pain in limb
1.5
8.3
439
3437
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
8.3
198
1304
Z49.2
ICD-10 Finland
Other dialysis
10.8
8.3
15
14
B05DB
ATC
Hypertonic solutions
10.8
8.3
15
14
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
3.6
8.3
27
77
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
8.2
47
186
SPAT1255
SPAT
Intravenous administration of medicine
2.2
8.2
72
345
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.3
8.2
59
260
A05AA02
ATC
ursodeoxycholic acid; oral
3.7
8.2
25
68
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
8.2
82
414
A06AD11
ATC
lactulose; oral
1.7
8.2
146
890
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
8.2
69
326
D06AX01
ATC
fusidic acid; topical
1.9
8.2
98
528
TNH31
NOMESCO Finland
Prefabricated orthosis, ankle or foot
4.6
8.1
19
42
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.3
8.1
30
93
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
8.2
8.1
17
21
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
11.8
8.1
14
12
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
11.8
8.1
14
12
M14.6*E10.6
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic neuropathic
17.3
8.1
12
7
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.9
8.1
36
125
QDA10
NOMESCO Finland
Incision of skin of lower limb
9.0
8.1
16
18
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.0
431
3379
V03AE03
ATC
lanthanum carbonate; oral
22.2
8.0
11
5
L04AA32
ATC
apremilast; oral
22.2
8.0
11
5
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
8.0
133
794
AN1
HP
Coronary angiography
1.9
8.0
108
605
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.3
8.0
30
94
J01AA02
ATC
doxycycline; systemic
1.5
7.9
765
6689
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
4.5
7.9
19
43
L73.2
ICD-10 Finland
Hidradenitis suppurativa
4.5
7.9
19
43
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
13.1
7.9
13
10
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
13.1
7.9
13
10
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.2
7.9
31
100
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
7.9
145
892
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
7.9
313
2312
L20
ICD-10 Finland
Atopic dermatitis
2.7
7.9
42
161
T90
ICPC
Diabetes non-insulin dependent
1.6
7.8
235
1633
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
10.9
7.8
14
13
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.5
7.8
318
2361
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
7.8
277
1999
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
7.8
97
530
L43.8
ICD-10 Finland
Other lichen planus
4.2
7.8
20
48
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.1
7.8
70
340
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
7.8
34
117
SPAT1211
SPAT
Application of soft bandage
1.9
7.7
94
509
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
15.1
7.7
12
8
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
45.3
7.7
9
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
4.0
7.6
21
53
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.0
7.6
21
53
R03DC03
ATC
montelukast; oral
1.7
7.6
168
1084
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
18.5
7.6
11
6
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
18.5
7.6
11
6
T89
ICPC
Diabetes insulin dependent
2.4
7.6
49
206
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
7.6
379
2923
R06.5
ICD-10 Finland
Mouth breathing
1.9
7.6
94
512
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.6
193
1291
L01BC02
ATC
fluorouracil; systemic, topical
8.9
7.6
15
17
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.9
7.5
22
58
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
7.5
67
324
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.5
7.5
46
189
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
7.5
178
1170
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
7.5
522
4280
K83.0
ICD-10 Finland
Cholangitis
3.9
7.5
21
54
H43.1
ICD-10 Finland
Vitreous haemorrhage
3.2
7.4
29
93
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.8
7.4
36
131
RJ511, ,
NOMESCO Finland
80.6
7.4
8
*
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
13.5
7.4
12
9
B35.4
ICD-10 Finland
Tinea corporis
4.1
7.4
20
50
SPAT1254
SPAT
Administration of medicine
1.7
7.4
155
988
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
7.4
229
1603
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
2.5
7.3
43
173
J01CE02
ATC
phenoxymethylpenicillin; oral
1.4
7.3
693
5988
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
+∞
7.3
7
*
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
7.3
78
404
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
7.3
132
808
A02BC05
ATC
esomeprazole; systemic
1.4
7.3
386
3007
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.3
7.2
55
249
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
7.2
128
778
V03AE01
ATC
polystyrene sulfonate; oral
5.8
7.2
19
33
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.4
7.2
49
211
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
4.5
7.2
17
38
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.2
280
2054
L88
ICPC
Rheumatoid/seropositive arthritis
2.5
7.2
43
175
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
30.2
7.2
9
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
7.1
211
1461
R04.2
ICD-10 Finland
Haemoptysis
2.6
7.1
39
152
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
12.1
7.1
12
10
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
7.1
105
606
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
7.1
109
637
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
7.0
94
525
B35.6
ICD-10 Finland
Tinea inguinalis [Tinea cruris]
3.2
7.0
27
86
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.0
7.0
30
102
H26.4
ICD-10 Finland
After-cataract
1.8
7.0
96
541
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
7.0
35
130
E66.00
ICD-10 Finland
Metabolic syndrome
2.1
7.0
61
293
ZY010
NOMESCO Finland
Hospital outpatient
2.2
7.0
58
273
C08CA01
ATC
amlodipine; oral
1.4
6.9
355
2741
A02BC01
ATC
omeprazole; systemic
1.5
6.9
259
1883
H3603, E103,
ICD-10 Finland
7.6
6.9
15
20
C09CA01
ATC
losartan; oral
1.5
6.9
240
1718
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.9
99
566
M05BA04
ATC
alendronic acid; oral
2.0
6.9
78
413
M54.5
ICD-10 Finland
Low back pain
1.4
6.8
367
2857
R03BB04
ATC
tiotropium bromide; inhalant
1.8
6.8
104
606
TGC00
NOMESCO Finland
Bronchial lavation
2.8
6.8
32
115
P01AB01
ATC
metronidazole; oral, rectal
1.4
6.8
380
2981
R03AC03
ATC
terbutaline; inhalant
1.7
6.8
133
832
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.3
6.8
17
40
NH3DG
NOMESCO Finland
Very extensive MRI of foot
40.3
6.8
8
*
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
16.8
6.7
10
6
J01CA04
ATC
amoxicillin; systemic
1.5
6.7
854
7723
A05
ICPC
Feeling ill
1.9
6.7
79
423
R11
ICD-10 Finland
Nausea and vomiting
1.8
6.7
96
548
SPAT1216
SPAT
Assessment of functional ability
1.6
6.7
151
978
A07EA06
ATC
budesonide; oral, local oral
2.4
6.7
44
187
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
22.7
6.7
9
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
6.7
105
617
L40.8
ICD-10 Finland
Other psoriasis
6.5
6.6
16
25
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.4
6.6
45
194
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
6.6
308
2333
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
6.6
105
620
A02BC03
ATC
lansoprazole; oral
1.5
6.6
266
1962
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
8.8
6.6
13
15
C09BA02
ATC
enalapril and diuretics; systemic
2.0
6.6
73
384
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
10.1
6.5
12
12
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
10.1
6.5
12
12
SPAT1210
SPAT
Application of cast or individual aid
2.3
6.5
46
202
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
6.5
103
607
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
6.5
262
1931
CBB30
NOMESCO Finland
Excision of lesion of eyelid
2.8
6.5
32
118
XKD00
NOMESCO Finland
Uroflowmetry
1.6
6.5
147
955
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.0
6.5
18
46
C10AX09
ATC
ezetimibe; oral
1.6
6.4
161
1070
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.3
6.4
23
70
C10AA01
ATC
simvastatin; oral
1.4
6.4
374
2947
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
6.4
336
2598
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
70.3
6.4
7
*
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
7.4
6.4
14
19
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.0
6.4
27
91
RJ421, ,
NOMESCO Finland
14.4
6.4
10
7
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.8
6.4
93
534
EBA00
NOMESCO Finland
Extraction of tooth
1.4
6.4
376
2969
L04AA13
ATC
[U] leflunomide
3.1
6.4
26
86
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
6.4
145
942
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
6.4
62
311
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
8.2
6.3
13
16
N02AC04
ATC
dextropropoxyphene; oral
2.5
6.3
38
155
M48.0
ICD-10 Finland
Spinal stenosis
1.7
6.3
119
736
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
6.3
57
278
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.1
6.3
58
285
WZC30
NOMESCO Finland
Teaching
1.6
6.3
159
1060
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
6.3
6
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
6.2
286
2157
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.0
6.2
62
313
A10BA02
ATC
metformin; oral
1.5
6.2
270
2015
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
26.8
6.2
8
*
RJ412, ,
NOMESCO Finland
26.8
6.2
8
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
26.8
6.2
8
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.1
6.2
25
82
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
3.2
6.2
24
77
R13
ICD-10 Finland
Dysphagia
1.9
6.2
71
378
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
2.5
6.2
38
157
I50.0
ICD-10 Finland
Congestive heart failure
1.9
6.2
70
371
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.5
6.2
37
151
L28.0
ICD-10 Finland
Lichen simplex chronicus
5.8
6.2
16
28
XCK00
NOMESCO Finland
Perimetry
2.1
6.2
60
301
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.3
6.1
47
214
A08
ICPC
Swelling
2.0
6.1
62
315
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.7
6.1
117
726
N05AF03
ATC
chlorprothixene; systemic
2.9
6.1
28
99
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
6.1
224
1618
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.2
6.1
49
228
K29.7
ICD-10 Finland
Gastritis, unspecified
2.5
6.1
38
158
196
Kela drug reimbursment
Paricalcitol and cinacalcet
12.6
6.1
10
8
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.5
6.1
35
140
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
8.7
6.1
12
14
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
8.7
6.1
12
14
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
3.2
6.0
23
73
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
6.0
172
1178
J01MA12
ATC
levofloxacin; systemic
1.6
6.0
169
1153
R06AX27
ATC
desloratadine; oral
1.4
6.0
282
2134
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
745
5398
2.21
31.65
13.5
9.6
4.33
4.10
e9/l
1.92
690
4668
218
974
2.55
30.33
14.4
6.4
—
—
—
0
0
451
2734
2.11
30.31
6.2
3.7
0.00
0.01
estimate
0.78
127
964
559
3771
1.99
27.01
5.8
3.6
0.06
0.02
estimate
0.45
119
876
587
4066
1.97
25.86
8.5
5.1
35.51
35.86
g/l
0.81
566
3833
374
2228
2.04
25.34
6.3
3.8
1.02
1.71
kg/l
0.50
245
1466
161
680
2.61
24.86
2.5
2.6
57.60
67.74
ml/min/173m2
2.72
81
288
673
4962
1.94
23.77
5.9
3.7
0.00
0.00
estimate
-0.00
143
1036
677
5019
1.93
23.31
6.0
3.7
10.32
4.77
estimate
0.22
146
1057
198
948
2.33
23.19
5.9
4.3
1.88
1.93
mmol/l
0.07
169
801
679
5051
1.92
22.99
5.9
3.8
0.00
0.31
estimate
0.51
135
998
150
648
2.53
21.99
1.9
1.5
—
—
—
0
0
165
766
2.36
20.60
3.3
2.7
10.39
10.77
g/l
0.66
153
704
69
202
3.58
20.16
9.4
5.8
160.75
444.26
iu/ml
0.95
16
23
195
986
2.19
19.82
6.1
4.2
5.98
5.84
kpa
0.95
190
959
172
836
2.26
19.22
5.4
3.8
4.77
4.51
kpa
1.01
167
812
578
4239
1.78
18.87
3.4
2.5
74.90
76.12
nmol/l
0.48
532
3824
836
6872
1.94
18.51
6.7
4.2
13.65
11.75
mm/h
3.00
809
6403
183
932
2.16
18.16
1.9
2.1
360.07
381.37
nmol/l
0.65
168
870
362
2345
1.82
17.76
4.2
2.7
351.75
343.22
umol/l
0.79
334
2078
93
353
2.79
17.56
1.5
1.2
1.38
1.69
u/ml
—
6
17
148
703
2.28
17.39
3.0
2.4
4.87
7.76
ug/l
2.29
135
629
400
2698
1.76
16.94
4.2
3.3
1823.35
1250.11
ng/l
1.04
357
2307
407
2768
1.75
16.69
2.9
2.2
184.00
251.05
u/l
0.94
388
2640
167
850
2.14
16.51
18.2
6.9
10.20
9.49
mmol/l
0.67
162
811
130
597
2.34
16.50
4.8
3.6
124.92
129.44
g/l
1.47
125
587
483
3462
1.71
16.28
5.5
3.7
46.46
71.96
ng/l
0.61
355
2408
137
648
2.28
16.23
1.5
1.3
221.21
229.66
u/ml
0.04
131
598
693
5509
1.71
15.61
7.6
5.2
7.00
6.60
mmol/l
3.91
663
5201
230
1342
1.91
15.45
4.3
2.4
21.23
23.20
%
1.64
219
1251
259
1577
1.84
15.20
4.4
2.4
11.62
13.45
umol/l
4.68
248
1467
854
7230
1.85
15.15
5.6
4.3
14.85
14.75
pmol/l
0.53
811
6632
65
220
3.08
15.08
1.8
1.4
—
—
—
0
0
420
2952
1.69
14.86
4.4
2.5
59.39
61.54
u/l
0.19
399
2750
371
2533
1.71
14.56
3.2
2.3
3.18
2.80
mg/l
1.98
343
2173
317
2075
1.75
14.47
2.2
1.8
1.08
1.26
mg/l
0.63
251
1598
322
2122
1.74
14.33
4.0
2.5
6.92
5.92
e6/l
0.41
303
1928
835
7065
1.79
14.28
12.5
7.9
83.60
79.82
u/l
1.08
810
6692
553
4223
1.63
13.82
18.0
14.1
1.26
1.24
inr
0.40
489
3535
239
1468
1.81
13.45
4.5
2.4
2.28
2.34
g/l
0.81
228
1358
74
291
2.66
13.05
1.6
1.4
—
—
—
0
0
619
4904
1.61
12.97
9.2
6.6
10.64
11.67
umol/l
2.24
598
4693
251
1587
1.76
12.73
6.2
3.8
0.81
0.82
mmol/l
0.82
236
1512
443
3252
1.61
12.67
4.3
3.3
7.29
7.80
mmol/l
1.57
392
2771
121
607
2.12
12.30
1.8
1.7
1.04
1.43
g/l
2.08
115
564
159
882
1.94
12.24
3.5
2.4
0.21
0.21
g/l
0.00
150
819
54
186
3.00
12.18
1.8
1.5
—
—
—
0
0
135
712
2.02
12.00
6.7
4.0
121.51
84.89
ng/l
2.44
122
628
436
3224
1.59
11.89
3.7
3.4
2.34
2.35
mmol/l
1.18
405
2937
36
98
3.77
11.74
1.5
1.6
—
—
—
0
0
591
4695
1.57
11.73
12.7
7.1
1.20
1.21
mmol/l
4.95
527
4057
244
1568
1.72
11.56
2.5
1.8
—
—
—
0
0
206
1262
1.78
11.54
15.0
5.6
1.09
1.05
mmol/l
1.50
199
1166
54
192
2.91
11.52
1.5
1.4
—
—
—
0
0
736
6164
1.60
11.51
6.3
4.5
72.10
1960.01
e6/l
—
10
93
539
4216
1.55
11.30
11.8
6.6
1.20
1.21
mmol/l
5.01
514
3895
64
253
2.63
11.19
1.9
1.6
—
—
—
0
0
408
3003
1.57
11.17
5.2
4.1
16.26
8.89
mg/mmol
0.86
289
1870
65
261
2.59
11.01
1.4
1.2
—
—
—
0
0
236
1530
1.69
10.74
1.9
1.7
1379.13
1168.92
nmol/l
2.23
203
1164
62
249
2.58
10.51
1.8
1.6
—
—
—
0
0
283
1935
1.63
10.44
1.8
1.8
450.59
35208254.72
pmol/l
2.12
239
1636
184
1121
1.77
10.44
2.3
1.8
—
—
—
0
0
146
829
1.88
10.42
2.6
2.8
74.59
70.07
e9/l
0.62
122
623
270
1827
1.64
10.38
2.9
3.0
2.44
2.45
mmol/l
0.42
247
1633
575
4620
1.52
10.28
4.3
3.1
128.54
119.71
ug/l
0.45
552
4309
51
188
2.80
10.21
2.3
2.4
205.54
98.54
ug/min
0.78
30
114
70
304
2.39
10.06
1.6
1.5
64.14
0.07
iu/ml
0.48
17
54
174
1056
1.77
9.98
4.3
4.0
225.88
251.01
u/l
1.89
169
1005
83
390
2.22
9.94
2.1
1.6
6.34
6.90
iu/ml
0.08
21
84
934
8417
1.78
9.92
8.5
6.1
40.85
38.91
mmol/mol
6.59
886
7886
188
1171
1.73
9.84
2.3
1.8
—
—
—
0
0
991
9107
2.01
9.75
27.3
15.0
22.56
24.72
mg/l
1.46
879
7455
518
4110
1.50
9.59
2.3
2.1
92.52
94.76
pmol/l
0.57
318
2184
78
363
2.24
9.57
2.1
1.9
1.94
2.48
ug/l
0.20
72
332
410
3105
1.51
9.48
4.9
3.2
30.58
77.55
e6/l
1.40
344
2367
942
8540
1.78
9.40
6.8
5.3
1.89
1.90
mu/l
0.09
898
7924
361
2672
1.53
9.25
4.4
3.1
0.30
0.43
e6/l
1.17
295
1958
30
86
3.56
9.12
1.6
1.7
—
—
—
0
0
169
1048
1.73
8.94
7.3
8.8
1.28
0.96
mmol/l
0.54
139
860
46
173
2.73
8.90
2.0
1.7
—
—
—
0
0
36
120
3.07
8.64
1.4
1.4
—
—
—
0
0
215
1437
1.62
8.52
3.2
2.1
29.21
29.48
s
0.31
210
1399
87
443
2.05
8.50
1.7
1.5
—
—
—
0
0
362
2720
1.50
8.48
1.8
1.7
19.94
20.21
nmol/l
0.12
318
2301
27
77
3.57
8.28
1.4
1.5
—
—
—
0
0
27
77
3.57
8.28
1.4
1.5
—
—
—
0
0
27
77
3.57
8.28
1.4
1.5
—
—
—
0
0
252
1760
1.56
8.26
1.5
1.3
38.66
29.92
iu/ml
0.44
84
536
41
152
2.76
8.16
1.6
1.5
—
—
—
0
0
118
680
1.82
8.00
5.9
3.8
5.21
5.14
kpa
0.32
112
657
57
251
2.34
7.98
2.2
1.6
—
—
—
0
0
1026
9673
2.10
7.43
32.3
19.3
84.38
76.51
umol/l
4.27
1018
9560
103
585
1.84
7.32
6.0
3.8
1.71
1.86
mmol/l
0.15
76
430
34
122
2.84
7.21
1.0
1.1
1.56
1.51
g/l
0.22
34
111
188
1274
1.58
6.94
3.2
2.5
135.86
115.13
ug/g
0.43
154
1010
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
60
289
2.14
6.81
4.5
3.4
0.35
0.39
iu/ml
0.29
35
152
311
2352
1.45
6.77
1.5
1.3
1.38
1.49
u/ml
0.10
98
618
232
1656
1.51
6.75
3.6
2.9
1.65
1.06
e6/l
0.64
153
879
123
754
1.71
6.75
2.6
3.0
64.88
67.04
g/l
2.79
115
702
25
79
3.22
6.59
4.2
2.5
818.32
1112.27
mg
0.46
25
79
988
9255
1.75
6.53
30.2
17.6
139.40
139.65
mmol/l
2.25
977
9071
77
414
1.93
6.49
2.6
2.4
858.42
6295.55
u/l
2.70
23
171
528
4406
1.39
6.48
3.3
2.8
—
—
estimate
—
0
0
21
60
3.55
6.46
2.1
3.0
—
—
—
0
0
66
338
2.01
6.39
1.8
1.6
—
—
—
0
0
228
1640
1.49
6.36
1.4
1.3
5.47
11.94
u/ml
1.33
86
613
20
56
3.62
6.33
1.2
1.2
—
—
—
0
0
988
9268
1.73
6.32
30.5
17.8
3.99
3.97
mmol/l
2.39
977
9063
23
71
3.29
6.30
1.4
1.3
—
—
—
0
0
48
220
2.24
6.18
1.9
1.4
229.85
237.29
u/ml
0.07
26
130
60
302
2.04
6.10
5.2
3.8
8.33
8.41
kpa
0.14
55
294
914
8433
1.53
6.06
5.7
4.1
1.39
1.27
mmol/l
4.70
859
7788
19
53
3.63
6.05
1.1
1.1
1654.84
1576.92
miu/ml
0.10
19
53
37
153
2.47
6.00
1.5
1.3
22.32
20.87
u/l
0.11
31
125
275
2074
1.44
5.98
1.8
1.5
2.54
2.36
g/l
0.65
199
1293
299
2295
1.42
5.88
2.6
2.3
—
—
—
0
0
935
8684
1.55
5.85
6.4
4.9
6.10
5.89
mmol/l
4.35
879
7985
22
70
3.19
5.76
1.4
1.3
—
—
—
0
0
20
60
3.38
5.74
1.9
2.7
930.67
498.50
e6/l
0.42
15
46
38
163
2.38
5.71
1.2
1.2
36.50
36.07
u/l
0.01
32
146
55
277
2.04
5.60
1.6
1.2
7.72
2.40
u/ml
—
6
22
29
111
2.66
5.51
1.1
1.0
—
—
—
0
0
42
192
2.24
5.47
2.0
1.5
141.89
148.59
au/ml
—
7
55
41
187
2.24
5.37
3.3
2.6
16.88
16.24
%
0.60
41
182
28
107
2.66
5.34
1.2
1.2
—
—
—
0
0
1009
9583
1.75
5.33
18.8
11.5
27.03
25.97
u/l
0.72
991
9314
395
3219
1.36
5.31
5.1
3.3
38.55
32.51
u/l
0.76
382
3046
31
128
2.46
5.08
2.3
1.7
—
—
—
0
0
22
76
2.93
5.05
2.4
2.1
—
—
—
0
0
15
32
4.74
5.00
1.1
1.3
—
—
—
0
0
29
118
2.50
4.90
1.4
1.8
18.65
34.97
ng/l
0.92
29
118
71
410
1.78
4.84
1.6
2.2
1.56
1.50
g/l
0.26
62
371
16
38
4.26
4.83
1.1
1.3
—
—
—
0
0
51
265
1.97
4.80
1.5
1.5
230.05
275.09
ug/g
0.84
30
156
705
6315
1.33
4.74
4.8
3.3
59.08
47.76
u/l
1.94
661
5964
68
391
1.79
4.70
2.5
2.0
41.11
38.95
u/l
0.37
63
345
107
696
1.60
4.69
1.8
1.5
—
—
—
0
0
45
226
2.03
4.66
1.6
1.2
36.56
66.10
u/ml
—
5
19
839
7725
1.38
4.64
35.0
19.6
331.90
332.68
g/l
1.77
834
7681
15
43
3.52
4.62
1.1
1.5
—
—
—
0
0
15
43
3.52
4.62
1.1
1.5
—
—
—
0
0
15
43
3.52
4.62
1.1
1.5
—
—
—
0
0
15
43
3.52
4.62
1.1
1.5
—
—
—
0
0
40
193
2.11
4.60
1.8
1.6
—
—
—
0
0
52
277
1.92
4.57
1.6
1.2
4.03
9.20
u/ml
—
7
37
48
250
1.96
4.51
1.6
1.4
—
—
—
0
0
90
567
1.64
4.49
1.4
1.3
40.16
51.49
au/ml
—
10
44
12
24
5.04
4.32
4.2
2.2
0.59
0.62
mmol/l
0.92
12
24
25
102
2.49
4.24
1.1
1.0
—
—
—
0
0
1036
9983
1.82
4.23
40.2
23.0
252.69
250.10
e9/l
0.61
1026
9788
18
62
2.94
4.18
2.7
2.7
37.54
38.63
%
0.08
11
31
153
1102
1.45
4.17
4.4
3.0
7.78
7.95
umol/l
0.04
135
969
1036
9988
1.81
4.15
40.2
22.9
4.48
4.50
e12/l
0.54
1022
9765
1036
9988
1.81
4.15
40.7
23.5
40.39
40.37
%
0.06
1031
9876
103
685
1.56
4.12
3.7
3.0
184.49
197.91
ng/l
0.14
96
625
1036
9990
1.80
4.12
40.3
23.0
7.00
6.75
e9/l
2.24
1024
9759
56
317
1.81
4.11
3.6
2.8
—
—
—
0
0
96
631
1.57
4.04
2.6
2.4
14.21
19.52
au/ml
—
8
60
47
254
1.89
3.99
1.3
1.1
—
—
—
0
0
47
254
1.89
3.99
1.3
1.1
—
—
—
0
0
49
269
1.86
3.97
1.3
1.2
—
—
—
0
0
922
8684
1.41
3.96
21.5
14.5
79.66
83.00
ml/min/173m2
3.98
864
7998
14
43
3.29
3.91
1.1
1.1
110.07
578.78
u/l
1.11
14
37
41
213
1.96
3.91
1.3
1.8
—
—
—
0
0
24
100
2.43
3.91
1.0
1.0
—
—
—
0
0
953
9034
1.45
3.90
7.1
5.5
2.60
2.70
mmol/l
3.16
900
8420
131
928
1.47
3.90
4.3
3.2
—
—
—
0
0
63
1015
0.60
3.90
2.5
1.9
3.61
3.45
ratio
0.44
51
799
8
12
6.71
3.67
1.0
1.1
—
—
—
0
0
8
12
6.71
3.67
1.0
1.1
—
—
—
0
0
8
12
6.71
3.67
3.3
2.1
—
—
—
0
0
14
40
3.53
3.61
1.1
1.0
—
—
—
0
0
937
8880
1.40
3.60
6.2
4.8
1.39
1.46
mmol/l
4.87
887
8263
41
220
1.90
3.58
1.8
1.7
10.50
30.92
e6/l
0.67
32
170
18
68
2.67
3.57
1.0
1.0
—
—
—
0
0
94
634
1.53
3.55
8.4
9.5
24.79
24.84
mmol/l
0.04
94
629
14
46
3.07
3.53
3.4
2.7
534.36
952.02
u/ml
0.82
14
46
106
735
1.49
3.52
9.8
3.6
1.21
1.23
mmol/l
1.23
94
621
41
222
1.88
3.49
1.8
1.8
70.43
822.57
e6/l
0.80
35
176
20
81
2.50
3.47
3.0
1.7
—
—
—
0
0
44
755
0.57
3.47
1.9
1.7
3.40
3.43
mmol/l
0.08
31
552
45
252
1.82
3.46
1.6
1.5
471.40
488.02
mg/l
0.13
45
239
238
1902
1.32
3.44
1.7
1.6
—
—
—
0
0
11
27
4.11
3.40
1.1
1.1
—
—
—
0
0
11
27
4.11
3.40
1.1
1.1
—
—
—
0
0
11
27
4.11
3.40
1.1
1.2
—
—
—
0
0
68
430
1.62
3.40
5.4
5.7
1.93
1.56
%
1.59
68
408
39
214
1.85
3.21
2.6
3.1
32.70
34.05
umol/l
0.19
34
191
938
8926
1.37
3.20
6.8
4.9
4.45
4.61
mmol/l
5.36
892
8357
8
15
5.36
3.19
2.8
1.2
—
—
—
0
0
15
56
2.70
3.06
1.1
1.0
0.98
1.09
u/l
—
8
30
13
41
3.20
3.06
3.3
3.4
—
—
—
0
0
40
226
1.80
3.02
2.8
2.4
128.61
129.95
g/l
0.10
28
176
327
2770
1.26
2.96
4.4
3.2
0.04
0.04
estimate
0.01
124
838
36
199
1.84
2.92
2.3
1.8
0.93
0.87
nmol/l
0.15
28
170
19
82
2.34
2.92
1.4
1.3
17113.71
172827.59
e6/l
1.09
14
56
21
95
2.23
2.91
1.8
1.7
62.60
61.05
%
0.06
15
67
10
27
3.73
2.88
1.1
1.1
—
—
—
0
0
10
27
3.73
2.88
2.6
1.6
14.03
14.74
pmol/l
—
10
22
32
171
1.90
2.88
1.6
1.4
0.26
0.36
nmol/l
0.84
26
137
7
13
5.41
2.87
1.0
1.0
—
—
—
0
0
90
638
1.45
2.72
2.3
1.9
—
—
—
0
0
12
43
2.81
2.65
3.8
3.7
0.92
1.05
%
0.12
12
43
27
141
1.94
2.62
1.4
1.2
—
—
—
0
0
9
25
3.62
2.57
4.0
3.1
5.44
5.84
ug/l
—
9
25
11
36
3.08
2.57
2.7
1.4
—
—
—
0
0
823
7763
1.25
2.53
28.3
19.0
13.80
13.57
%
5.53
818
7666
10
31
3.25
2.52
1.2
1.6
—
—
—
0
0
10
31
3.25
2.52
1.2
1.6
—
—
—
0
0
81
575
1.44
2.45
3.6
3.6
4.42
4.60
pmol/l
0.93
76
513
10
32
3.14
2.44
1.2
1.6
—
—
—
0
0
25
131
1.93
2.42
2.3
1.7
—
—
—
0
0
434
3856
1.21
2.41
2.4
1.9
1.44
1.34
mmol/l
1.97
368
3272
9
27
3.35
2.39
1.1
1.1
—
—
—
0
0
69
485
1.45
2.22
1.4
1.3
—
—
—
0
0
11
41
2.70
2.21
1.2
1.2
108.64
104.66
%
0.24
11
35
32
188
1.72
2.19
6.1
9.5
103.16
105.58
mmol/l
1.17
32
172
18
87
2.09
2.18
2.5
2.8
18.18
24.95
nmol/l
2.49
18
79
31
181
1.73
2.17
1.1
1.1
2.97
15.32
au/ml
—
6
54
277
2381
1.22
2.12
6.1
4.1
90.63
89.79
%
0.22
268
2331
642
5961
1.19
2.08
3.3
3.1
—
—
—
0
0
55
377
1.48
2.03
1.6
1.6
261.62
299.13
mu/l
0.75
50
345
11
44
2.52
2.01
3.8
2.0
1.95
1.97
umol/l
0.03
11
38
19
349
0.54
1.99
1.1
1.1
1.40
1.54
g/l
2.26
19
349
38
241
1.60
1.98
1.7
1.7
6707.59
14332.77
e6/l
1.39
32
171
20
105
1.92
1.96
1.7
1.2
—
—
—
0
0
48
325
1.50
1.89
1.6
1.4
10.98
8.16
u/l
0.51
39
255
12
52
2.32
1.88
1.2
1.1
—
—
—
0
0
20
107
1.89
1.87
1.7
1.2
—
—
—
0
0
20
107
1.89
1.87
1.7
1.2
—
—
—
0
0
33
207
1.61
1.81
3.4
4.1
67.18
61.55
%
0.75
33
207
7
23
3.06
1.80
1.4
1.1
105.00
95.87
%
—
7
23
8
29
2.77
1.79
1.5
1.3
9.79
9.48
ug/l
—
8
29
99
771
1.31
1.76
2.5
2.0
—
—
—
0
0
174
1453
1.24
1.76
1.7
1.5
—
—
—
0
0
38
249
1.55
1.75
4.9
3.5
6.07
2.21
index
1.99
15
140
50
349
1.45
1.72
2.4
1.8
—
—
—
0
0
71
529
1.37
1.70
1.1
1.1
—
—
—
0
0
14
69
2.04
1.65
1.0
1.1
291.50
283.55
mg/l
0.13
14
62
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
56
2.16
1.61
1.2
1.1
—
—
—
0
0
87
1108
0.77
1.60
5.3
4.7
33.40
31.99
%
0.51
68
735
35
231
1.53
1.58
1.3
1.2
—
—
—
0
0
10
44
2.28
1.55
2.5
1.8
130.30
61.83
ug/l
—
10
44
13
64
2.04
1.54
1.7
1.5
—
—
—
0
0
18
100
1.81
1.53
1.3
1.4
—
—
—
0
0
49
350
1.42
1.52
1.2
1.3
199.28
252.51
miu/ml
0.36
19
172
18
101
1.80
1.49
1.5
1.2
—
—
—
0
0
18
101
1.80
1.49
1.5
1.2
—
—
—
0
0
58
430
1.37
1.46
1.6
1.7
0.44
0.32
mg/l
0.47
26
204
9
38
2.38
1.45
1.0
1.1
—
—
—
0
0
18
102
1.78
1.45
1.5
1.2
—
—
—
0
0
12
60
2.01
1.38
9.6
3.6
1.08
1.00
index
0.13
12
60
17
286
0.59
1.38
1.5
1.5
0.93
0.93
ratio
—
10
190
17
286
0.59
1.38
1.5
1.5
1.42
1.18
ratio
—
10
190
17
286
0.59
1.38
1.5
1.5
1.17
1.16
ratio
—
10
190
205
1785
1.18
1.36
4.7
3.9
454.95
534.61
ng/l
0.13
149
1345
14
75
1.88
1.34
1.4
2.6
3.88
2.00
u/field
—
8
42
27
176
1.55
1.32
1.4
1.3
—
—
—
0
0
27
176
1.55
1.32
1.4
1.3
—
—
—
0
0
42
301
1.41
1.31
2.4
3.9
44.97
66.86
mg/l
0.56
37
264
9
43
2.10
1.30
1.3
1.2
—
—
—
0
0
17
281
0.60
1.30
1.5
1.5
—
—
—
0
0
16
91
1.77
1.29
1.1
1.0
—
—
—
0
0
72
564
1.30
1.28
8.4
10.5
24.49
24.39
mmol/l
0.10
72
553
45
330
1.38
1.24
1.2
1.4
—
—
—
0
0
25
163
1.55
1.24
1.1
1.0
6.80
4.71
u/ml
0.27
14
84
9
45
2.01
1.23
1.6
2.0
—
—
—
0
0
12
63
1.91
1.23
1.3
1.3
—
—
—
0
0
10
49
2.05
1.22
1.4
1.2
—
—
—
0
0
10
49
2.05
1.22
1.4
1.2
—
—
—
0
0
14
78
1.81
1.21
1.2
1.4
—
—
—
0
0
28
189
1.49
1.19
1.1
1.1
1.32
1.21
u/ml
0.08
18
102
255
2283
1.15
1.19
5.0
4.6
25.18
21.44
%
3.14
143
1106
24
355
0.67
1.15
1.4
1.5
—
—
—
0
0
30
208
1.45
1.13
2.4
1.5
—
—
—
0
0
7
30
2.34
1.12
1.9
3.7
4.06
5.09
kpa
—
7
30
7
30
2.34
1.12
1.9
3.7
11.23
10.15
kpa
—
7
30
41
302
1.37
1.12
2.4
3.8
46.32
84.70
mg/l
0.48
36
265
25
364
0.68
1.11
1.4
1.2
0.87
0.90
g/l
0.31
25
364
85
695
1.24
1.10
1.2
1.2
103.64
136.02
u/ml
0.34
28
279
139
1200
1.18
1.04
1.8
1.8
1.54
1.45
%
0.86
121
1051
39
290
1.36
1.02
1.3
1.3
—
—
—
0
0
140
1218
1.17
0.97
2.5
2.1
—
—
—
0
0
149
1695
0.86
0.96
3.4
3.3
0.71
0.77
ug/l
0.62
100
1091
47
367
1.29
0.91
3.4
3.7
4780.54
3906.30
u/ml
0.06
41
319
14
86
1.64
0.91
1.6
1.1
52.14
52.01
u/l
0.01
14
77
40
306
1.32
0.90
1.8
1.4
—
—
—
0
0
12
71
1.70
0.89
1.3
1.0
—
—
—
0
0
16
104
1.55
0.85
1.4
1.8
—
—
—
0
0
19
129
1.48
0.83
1.3
1.1
—
2.40
—
0
5
26
188
1.39
0.83
1.2
1.1
3.28
6.56
u/ml
0.73
17
109
6
115
0.52
0.83
1.3
1.9
13.38
13.13
%
—
6
115
21
147
1.44
0.80
1.1
1.1
6.14
6.42
u/ml
0.02
12
66
109
948
1.17
0.78
3.4
4.5
17.20
26.08
ug/l
0.32
87
781
35
269
1.31
0.78
2.1
2.0
1.87
4.08
iu/l
2.97
15
114
148
1319
1.14
0.77
2.7
2.2
—
—
—
0
0
5
24
2.09
0.74
1.2
1.2
—
—
—
0
0
55
452
1.23
0.73
5.8
3.5
1.02
1.02
ratio
0.14
50
425
7
38
1.85
0.73
1.0
1.2
—
—
—
0
0
9
55
1.64
0.73
2.0
1.6
—
—
—
0
0
44
353
1.26
0.73
1.8
1.7
2.91
9.35
u/ml
—
8
83
14
92
1.53
0.72
1.3
1.2
—
—
—
0
0
10
61
1.65
0.68
1.0
1.7
17.53
13.36
umol/l
—
10
56
40
321
1.26
0.67
2.4
1.7
—
—
—
0
0
7
43
1.63
0.67
1.0
1.2
4.14
8.53
mm/h
—
7
43
7
43
1.63
0.67
2.6
2.6
56.41
43.68
umol/l
—
7
37
12
79
1.52
0.62
1.9
1.7
—
—
—
0
0
20
148
1.36
0.60
1.4
1.1
—
1.19
—
0
6
11
72
1.53
0.59
1.3
1.4
1.82
1.90
mmol/l
0.18
11
66
302
2843
1.09
0.59
5.0
5.6
4.37
2.86
ug/l
0.26
276
2551
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
6
36
1.67
0.56
1.2
1.1
—
—
—
0
0
6
36
1.67
0.56
1.5
1.1
—
—
—
0
0
8
55
1.46
0.56
3.3
2.0
167.42
103.39
ng/l
—
8
55
24
307
0.78
0.56
1.5
1.6
48.01
59.61
ug/l
0.80
19
270
9
61
1.48
0.53
2.2
1.5
73.67
82.13
umol/l
—
9
61
45
532
0.84
0.52
1.4
1.6
681.77
957.98
mu/l
2.49
35
457
28
224
1.26
0.51
1.2
1.1
1.04
1.94
u/ml
0.65
16
128
38
315
1.21
0.51
1.5
1.9
41.13
39.88
nmol/l
0.11
38
299
19
145
1.32
0.49
4.7
2.6
5.64
8.58
umol/l
0.60
14
104
11
77
1.43
0.45
1.3
1.2
—
—
—
0
0
12
86
1.40
0.44
1.5
1.1
91.00
110.66
pmol/l
0.49
12
86
5
32
1.57
0.42
1.4
1.8
39.88
41.64
g/l
—
5
32
0
17
0.00
0.40
0.0
8.5
—
10.56
—
0
17
92
836
1.11
0.40
2.4
2.4
13.39
12.91
nmol/l
0.21
84
752
5
35
1.43
0.39
2.2
2.5
—
—
—
0
0
13
98
1.33
0.37
2.5
3.4
—
—
—
0
0
32
272
1.18
0.36
2.4
3.7
2.91
2.35
ratio
0.13
22
163
11
81
1.36
0.36
1.3
1.2
—
—
—
0
0
11
81
1.36
0.36
1.3
1.2
—
—
—
0
0
6
42
1.43
0.35
1.3
1.5
5.28
6.23
mmol/l
—
6
42
17
135
1.26
0.35
1.6
1.2
2.40
5.78
u/ml
—
10
58
17
136
1.25
0.33
1.6
1.2
1.29
5.00
u/ml
—
7
52
17
137
1.24
0.32
1.1
1.0
0.06
0.44
u/ml
—
7
40
7
52
1.35
0.31
2.1
1.2
—
—
—
0
0
7
57
1.23
0.29
2.3
1.6
—
—
—
0
0
62
565
1.10
0.28
2.1
1.6
—
—
—
0
0
11
139
0.79
0.27
1.5
1.6
—
—
—
0
0
164
1564
1.06
0.25
4.3
3.0
4.69
2.54
e6/l
0.51
87
783
11
87
1.27
0.24
1.3
1.2
—
—
—
0
0
5
40
1.25
0.22
1.0
1.2
—
—
—
0
0
23
200
1.15
0.22
6.0
3.5
31.91
27.63
mg/l
0.21
16
132
31
276
1.13
0.22
2.1
2.6
0.00
0.00
g/l
-0.00
24
244
5
41
1.22
0.22
2.2
1.6
0.64
0.50
e9/l
—
5
41
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
6.14
—
0
10
0
12
0.00
0.21
0.0
1.2
—
19.40
—
0
7
36
325
1.11
0.21
2.1
2.7
0.41
1.29
g/l
1.66
29
291
10
80
1.25
0.20
1.3
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
7
62
1.13
0.17
1.0
1.4
121.20
180.42
pmol/l
—
7
62
5
67
0.75
0.17
1.2
1.1
—
—
—
0
0
6
78
0.77
0.15
1.0
1.7
—
—
—
0
0
11
129
0.85
0.14
1.1
1.3
0.53
0.61
nmol/l
0.60
11
124
20
219
0.91
0.11
1.5
1.8
—
—
—
0
0
26
242
1.08
0.09
1.5
1.9
180.58
211.43
pmol/l
0.83
26
230
14
126
1.11
0.09
1.3
1.1
—
—
—
0
0
17
185
0.92
0.08
1.4
1.6
53.35
52.57
ug/l
0.02
17
185
14
127
1.10
0.08
1.4
1.1
—
—
—
0
0
12
133
0.90
0.07
1.3
1.2
—
—
—
0
0
93
906
1.03
0.07
3.6
2.3
34.12
34.84
u/l
0.05
84
754
8
75
1.07
0.07
1.0
1.8
—
—
—
0
0
11
102
1.08
0.03
1.4
1.4
6.39
6.85
mmol/l
0.09
11
95
24
249
0.96
0.02
1.5
1.7
—
—
—
0
0
12
127
0.94
0.01
1.1
1.3
301.33
350.54
pmol/l
—
6
113
16
166
0.96
0.00
1.9
1.6
—
—
—
0
0
36
364
0.99
0.00
3.1
1.8
4.93
3.89
mg/l
0.33
31
261
29
287
1.01
0.00
2.2
2.6
0.00
0.03
g/l
0.72
24
261
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
142.40
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
56.50
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint L12_EPIDERMTHICKNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_EPIDERMTHICKNAS | 1.228 [1.06, 1.42] | 0.007 |
| Birth year | 0.994 [0.99, 1.0] | 0.146 |
During the follow-up period (1.1.1998 — 31.12.2019), 517 out of 3191 females with L12_EPIDERMTHICKNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_EPIDERMTHICKNAS | 1.233 [1.05, 1.44] | 0.009 |
| Birth year | 0.988 [0.98, 1.0] | 0.011 |
During the follow-up period (1.1.1998 — 31.12.2019), 555 out of 2752 males with L12_EPIDERMTHICKNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_EPIDERMTHICKNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.112% | 0.254% |
| 5 | 0.796% | 1.429% |
| 10 | 1.809% | 3.74% |
| 15 | 3.451% | 7.347% |
| 20 | 6.151% | 12.246% |
Relationships between endpoints
↥Index endpoint: L12_EPIDERMTHICKNAS – Other and unspecified epidermal thickening
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data